13F Portfolios

SurgoCap Partners LP: INTUITIVE SURGICAL INC (ISRG): Quarterly 13F Position History

As of Q1 2026, SurgoCap Partners LP reported 333,032 shares of INTUITIVE SURGICAL INC (ISRG), worth $153.5M and representing 5.1% of its 13F equity book. Quarter-over-quarter share count change: + 70,181 (+26.7%) . The position first appeared in Q4 2023 and has been disclosed across 10 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 10 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 333,032 +70,181 +26.7% $153.5M 5.1% $461.0
Q4 2025 262,851 +262,851 $148.9M 4.1% $566.4
Q3 2025 0 0 $0 0.0%
Q2 2025 0 0 $0 0.0%
Q1 2025 0 0 $0 0.0%
Q4 2024 0 0 $0 0.0%
Q3 2024 0 0 $0 0.0%
Q2 2024 0 0 $0 0.0%
Q1 2024 0 166,338 -100.0% $0 0.0%
Q4 2023 166,338 $56.1M 4.0% $337.4

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did SurgoCap Partners LP first disclose a ISRG position in 13F-HR filings?

SurgoCap Partners LP first reported INTUITIVE SURGICAL INC (ISRG) on its 13F-HR filing for the period ending 2023-12-31 (Q4 2023). The position has appeared on 10 reported quarters within Pactolio's tracked window.

What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in ISRG?

Between Q4 2025 and Q1 2026, SurgoCap Partners LP added 70,181 shares of ISRG (+26.7%), bringing the total reported position to 333,032 shares at a market value of $153.5M.

Does the implied price-per-share represent SurgoCap Partners LP's cost basis in ISRG?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.